The association between symptomatic dizziness and vestibular disorders and the subsequent risk of falls and other injuries.
Organon makes $1.2bn play for Roivant’s immuno-dermatology subsidiary – Pharmaceutical Technology
The deal includes a $175m upfront payment for Roivant’s subsidiary Dermavant. Image credit: Shutterstock / testing. Organon is set to acquire Roivant’s immuno-dermatology subsidiary Dermavant